Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
2.65M
-
Shares change
-
+2.65M
-
Total reported value, excl. options
-
$24.4M
-
Value change
-
+$24.4M
-
Number of buys
-
16
-
Price
-
$9.22
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q3 2016
16 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2016.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.65M shares
of 30.2M outstanding shares and own 8.76% of the company stock.
Largest 10 shareholders include Cormorant Asset Management, LLC (800K shares), WELLINGTON MANAGEMENT GROUP LLP (603K shares), PUTNAM INVESTMENTS LLC (370K shares), Monashee Investment Management LLC (280K shares), Alyeska Investment Group, L.P. (150K shares), BAKER BROS. ADVISORS LP (125K shares), MILLENNIUM MANAGEMENT LLC (88.5K shares), Point72 Asset Management, L.P. (80K shares), Nationwide Fund Advisors (72.9K shares), and Laurion Capital Management LP (30K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.